Literature DB >> 24634898

A Comparison of Immune Functionality in Viral versus Non-Viral CFS Subtypes.

Nicole Porter1, Athena Lerch2, Leonard A Jason, Matthew Sorenson, Mary Ann Fletcher, Joshua Herrington.   

Abstract

Participants with CFS were grouped into viral and non-viral onset fatigue categories and assessed for differential immunological marker expression. Peripheral Blood Mononuclear Cells were assessed for differential phenotypic expression of surface adherence glycoproteins on circulating lymphocytes. The flow cytometric analysis employed fluorescent monoclonal antibody labeling. The viral in comparison to the non-viral group demonstrated significant elevations in several Th1 type subsets including: the percentage and number of CD4+ cells, the percentage and number of CD2+CD26+ cells, the percentage and number of CD2+CD4+CD26+ cells, the percentage and number of CD4+ CD26+ cells, and the percentage of Th2 naïve cells (CD4+ CD45RA+CD62L+). Of the remaining significant findings, the non viral group demonstrated significant elevations in comparison to the viral group for the following Th1 type subsets: the percentage of CD8+ cells, the percentage of T-cytotoxic suppressor cells (CD3+8+), and the percentage and number of Th1 memory cells (CD8+CD45RA-CD62L-). The viral group demonstrated a pattern of activation that differed from that of the group with a non-viral etiology, as evidenced by an elevated and out of range percentage and number of CD4+ cells, the percentage of CD2+CD26+, and the percentage of Th2 naïve cells (CD4+CD45RA+CD62L+). Both groups demonstrated reduced and out of range Natural Killer Cell Cytotoxicity and percentage of B-1 cells (CD5+CD19). In addition, both groups demonstrated an elevated and out of range percentage of CD2+CD8+CD26+, percentage of the Th1 memory subset (CD4+CD45RA-CD62L-), the percentage of Th1 memory and naïve cells (CD8+CD45RA-CD62L-, CD8+CD45RA+CD62L-), the percentage and number of Th2 memory cells (CD4+CD45RA-CD62L+), and the percentage of Th2 memory and naïve cells (CD8+CD45RA-CD62L+, CD8+CD45RA+CD62L+). These findings imply that the homeostatic mechanism responsible for the regulation of the Th1 (cell mediated) and Th2 (humoral) immune responses is disturbed in CFS. The implications of these findings are discussed.

Entities:  

Keywords:  Chronic Fatigue Syndrome; Immune Functionality; Viral Onset

Year:  2010        PMID: 24634898      PMCID: PMC3951052     

Source DB:  PubMed          Journal:  J Behav Neurosci Res


  26 in total

1.  Chronic fatigue syndrome is associated with diminished intracellular perforin.

Authors:  K J Maher; N G Klimas; M A Fletcher
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment.

Authors:  Pasquine Saule; Jacques Trauet; Virginie Dutriez; Véronique Lekeux; Jean-Paul Dessaint; Myriam Labalette
Journal:  Mech Ageing Dev       Date:  2005-12-13       Impact factor: 5.432

3.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.

Authors:  Liya Qin; Xuefei Wu; Michelle L Block; Yuxin Liu; George R Breese; Jau-Shyong Hong; Darin J Knapp; Fulton T Crews
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

4.  Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome.

Authors:  Michael Maes; Francis Coucke; Jean-Claude Leunis
Journal:  Neuro Endocrinol Lett       Date:  2007-12       Impact factor: 0.765

5.  Why does the thymus involute? A selection-based hypothesis.

Authors:  Mark R Dowling; Philip D Hodgkin
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

6.  Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients.

Authors:  D V Ablashi; H B Eastman; C B Owen; M M Roman; J Friedman; J B Zabriskie; D L Peterson; G R Pearson; J E Whitman
Journal:  J Clin Virol       Date:  2000-05       Impact factor: 3.168

7.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

8.  Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach.

Authors:  J K S Chia; A Y Chia
Journal:  J Clin Pathol       Date:  2007-09-13       Impact factor: 3.411

9.  Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells.

Authors:  D Rukavina; G Laskarin; G Rubesa; N Strbo; I Bedenicki; D Manestar; M Glavas; S E Christmas; E R Podack
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

10.  Plasma cytokines in women with chronic fatigue syndrome.

Authors:  Mary Ann Fletcher; Xiao Rong Zeng; Zachary Barnes; Silvina Levis; Nancy G Klimas
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

View more
  3 in total

1.  Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome.

Authors:  Emily G Lattie; Michael H Antoni; Mary Ann Fletcher; Frank Penedo; Sara Czaja; Corina Lopez; Dolores Perdomo; Andreina Sala; Sankaran Nair; Shih Hua Fu; Nancy Klimas
Journal:  Brain Behav Immun       Date:  2012-03-06       Impact factor: 7.217

2.  The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.

Authors:  Frank N M Twisk
Journal:  Front Physiol       Date:  2014-03-27       Impact factor: 4.566

3.  Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.

Authors:  Carmen Scheibenbogen; Franziska Sotzny; Jelka Hartwig; Sandra Bauer; Helma Freitag; Kirsten Wittke; Wolfram Doehner; Nadja Scherbakov; Madlen Loebel; Patricia Grabowski
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.